Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

$Multi-center study explores new treatment for heart failure patients with preserved and reduced ejection fraction$

News | Heart Failure

No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...

May 20, 2022

New Analysis Shows the Evolution of Intervention Techniques in Chronic Total Occlusion Patients

News | Chronic Total Occlusion (CTO)

International Chronic Total Occlusion Percutaneous Coronary Intervention Registry Finds Increasing Procedural Success

May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion ...

May 20, 2022

Three years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at SCAI22.

News | Peripheral Artery Disease (PAD)

New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

May 20, 2022

The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function.

News | Heart Valve Technology

First Intermediate to Long-term Study of the Harmony Transcatheter Pulmonary Valve System Validates Safety and Efficacy

May 19, 2022 — A study of 1-year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) ...

May 19, 2022

First multi-center, randomized controlled study provides the largest long-term evidence for the treatment of heavily calcified femoropopliteal lesions

News | Peripheral Artery Disease (PAD)

Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

May 19, 2022

The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

News | STEMI

International COVID-19 Registry Finds Significant Increased Risk of In-hospital Mortality for STEMI Patients with COVID-19 Compared to Pre-pandemic

May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking ...

May 19, 2022

30-day findings from the DIPRA study demonstrate distal radial artery access poses no increased hand dysfunction risk

News | Radial Access

Novel Distal Radial Access for Cardiac Catheterization Shown as a Safe Strategy Compared to Conventional Radial Access

May 19, 2022 — Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and ...

May 19, 2022

Results show potential to monitor ECG data in a non-clinical setting

News | Wearables

New App for Apple Watch Uses Artificial Intelligence to Detect Left-ventricular Dysfunction

May 18, 2022 — A new app developed by the Mayo Clinic transmits Apple Watch electrocardiograms (ECG) signals recorded in ...

May 18, 2022

Preliminary findings include a 15% relative CVD risk reduction within eight weeks

News | Womens Cardiovascular Health

Time-restricted Eating May Lower CVD Risk for Older Breast Cancer Survivors

May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...

May 18, 2022

Findings help identify patients who may not be optimally managed for recurrent stroke prevention

News | Stroke

Continuous Monitoring Detects Four Times More Atrial Fibrillation Incidence Following Stroke than Intermittent Monitoring

May 18, 2022 — Continuous monitoring with an insertable cardiac monitor (ICM) is shown to be more successful in ...

May 18, 2022

Khaldoon Alaswad, M.D., director of catheterization lab at Henry Ford Hospital in Detroit. Image courtesy of Henry Ford Health

News | Chronic Total Occlusion (CTO)

Henry Ford Cardiologist to Perform a Live Heart Procedure at International Medical Education Event

May 18, 2022 — For the third straight year, Henry Ford Hospital interventional cardiologist Khaldoon Alaswad, M.D. will ...

May 18, 2022

Results indicate Black patients are 25% less likely to receive stroke-preventing medication

News | Atrial Fibrillation

Study of National Registry Uncovers Racial Disparities Around Anticoagulation for Atrial Fibrillation

May 17, 2022 — Results of a new study reveal Black patients hospitalized with atrial fibrillation (AF) are under ...

May 17, 2022

Innovative care strategy created in response to COVID-19 pandemic emphasizes the role telemedicine plays in post-op patient monitoring

News | Atrial Fibrillation

New Study Shows Benefits of Same Day Discharge for Atrial Fibrillation Ablation Patients

May 17, 2022 — Results from a new study show success of intended same day discharge (SDD) improves over time for ...

May 17, 2022

Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding this year's conference. More than 7,700+ heart rhythm professionals from around the world whose participation during Heart Rhythm 2022

News | HRS

Heart Rhythm 2022 Highlights

May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...

May 17, 2022

Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA (icosapent ethyl) to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs

News | Pharmaceuticals

Research Shows Potential to Reduce Major Cardiovascular (CV) Events

May 17, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...

May 17, 2022